1. Home
  2. LRMR vs AEHR Comparison

LRMR vs AEHR Comparison

Compare LRMR & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • AEHR
  • Stock Information
  • Founded
  • LRMR N/A
  • AEHR 1977
  • Country
  • LRMR United States
  • AEHR United States
  • Employees
  • LRMR N/A
  • AEHR N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • AEHR Electrical Products
  • Sector
  • LRMR Health Care
  • AEHR Industrials
  • Exchange
  • LRMR Nasdaq
  • AEHR Nasdaq
  • Market Cap
  • LRMR 426.9M
  • AEHR 370.2M
  • IPO Year
  • LRMR N/A
  • AEHR 1997
  • Fundamental
  • Price
  • LRMR $3.19
  • AEHR $11.43
  • Analyst Decision
  • LRMR Strong Buy
  • AEHR Hold
  • Analyst Count
  • LRMR 9
  • AEHR 2
  • Target Price
  • LRMR $19.44
  • AEHR $12.00
  • AVG Volume (30 Days)
  • LRMR 639.4K
  • AEHR 879.1K
  • Earning Date
  • LRMR 03-13-2025
  • AEHR 04-08-2025
  • Dividend Yield
  • LRMR N/A
  • AEHR N/A
  • EPS Growth
  • LRMR N/A
  • AEHR 6.35
  • EPS
  • LRMR N/A
  • AEHR 0.75
  • Revenue
  • LRMR N/A
  • AEHR $50,735,000.00
  • Revenue This Year
  • LRMR N/A
  • AEHR $5.83
  • Revenue Next Year
  • LRMR N/A
  • AEHR $23.36
  • P/E Ratio
  • LRMR N/A
  • AEHR $15.18
  • Revenue Growth
  • LRMR N/A
  • AEHR N/A
  • 52 Week Low
  • LRMR $3.01
  • AEHR $9.83
  • 52 Week High
  • LRMR $12.91
  • AEHR $21.44
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 37.56
  • AEHR 46.65
  • Support Level
  • LRMR $3.06
  • AEHR $10.60
  • Resistance Level
  • LRMR $3.52
  • AEHR $12.81
  • Average True Range (ATR)
  • LRMR 0.22
  • AEHR 0.59
  • MACD
  • LRMR 0.02
  • AEHR 0.23
  • Stochastic Oscillator
  • LRMR 15.66
  • AEHR 49.82

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

Share on Social Networks: